BCC Taps 7% Credit Facility for $10 Million for Expansion

Visit the MPX Bioceutical Corporation Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

BCC Announces Initial US$10 Million Drawdown on Credit Facility

Resignation of Director

TORONTO, Oct. 24, 2017 (GLOBE NEWSWIRE) — The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced that it made an initial drawdown of US$10 million under the US$25 million revolving credit facility originally announced in the Corporation’s press release of May 3, 2017. The funds drawn down against the facility will be earmarked specifically for making further acquisitions, capacity expansion and the development of new facilities in Massachusetts and Maryland.

The lender shall have the right to convert outstanding principal amount of the initial drawdown plus any accrued interest (accruing at the rate of 7% per annum calculated and compounding on a monthly basis) into common shares of the Company at a conversion price of CAD$0.50 per common share.

The funds available to us through the credit facility are an attractive form of capital that will allow the Company to continue to aggressively pursue our expansion strategy and also fund our organic growth plans currently underway.

Scott Boyes, CEO

Resignation of Director

The Company also announced today that Marilyn Bloovol resigned from the Company’s board of directors. On behalf of all shareholders, the board thanks Ms. Bloovol for her years of service and leadership to BCC and we wish Ms. Bloovol all the best in her future endeavors.

The Company will not appoint a replacement for Ms. Bloovol prior to the forthcoming annual general and special meeting (the “Annual Meeting”) of the shareholders of the Company to be held at 11:00 a.m. (Toronto time) on Monday, October 30, 2017.

At the forthcoming Annual Meeting, the persons to be nominated by management to be elected as directors of the Company at the Annual Meeting are as follows:

  • W. Scott Boyes
  • Robert R. Galvin
  • Andrew R. Ryan
  • Randall G. Stafford
  • Elizabeth M. Stavola
  • Senator Richard S. (“Tick”) Segerblom
  • Dr. Miles D. Thompson

About The Canadian Bioceutical Corporation

BCC, an Ontario corporation, through its wholly owned subsidiaries in the U.S., provides substantial management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services to two medicinal cannabis enterprises in Arizona operating under the Health for Life (dispensaries) and the award-winning Melting Point Extracts (“MPX”) (high-margin concentrates wholesale) brands. The successful Health for Life (“H4L”) brand operates in the rapidly growing Phoenix Metropolitan Statistical Area (MSA). The Company also owns assets in Massachusetts, supporting cultivation, production and up to three dispensaries in Massachusetts, as well as is supporting development of a third licensed dispensary in Arizona.

BCC continues to expand its U.S. footprint, being in the process of acquiring three dispensaries and a production license in Maryland, as well as a further operational dispensary in Arizona. The Company also leases a property in Owen Sound, Ontario, for which an application to Health Canada has been made for a cannabis production and sales license. In addition, the Company will continue its efforts to develop its legacy nutraceuticals business.

Original press release: https://www.globenewswire.com/news-release/2017/10/24/1152748/0/en/BCC-Announces-Initial-US-10-Million-Drawdown-on-Credit-Facility.html

The most reliable, fact-based information on MPX Bioceutical Corp found only on its Investor Dashboard.

Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter